Rocket Doctor AI (AIDR.CN) Stock Analysis & Winston Score
Rocket Doctor AI Inc. is a Canadian digital health company that connects patients with licensed doctors through an online platform. Instead of visiting a clinic in person, patients can book virtual appointments and get medical care from their phones or computers. The company operates in the telehealth industry and uses artificial intelligence tools to help doctors work more efficiently. Rocket Doctor AI makes money by charging fees for virtual medical consultations, either directly to patients or through healthcare system partnerships. The company is based in Canada and is relatively small, with a market cap around $100 million. Its high gross margin suggests the software platform itself is efficient, but the deeply negative operating margin means it is spending far more than it earns — a common but serious challenge for early-stage health tech companies. The key risk is whether the company can grow its patient and physician base fast enough to reach profitability before it needs to raise additional capital.
Winston Score: 34/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: 0.60 CAD
Market Cap: 58M CAD
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: Canadian Securities Exchange
